Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Correlation between platelet thrombus formation on collagen-coated beads and platelet aggregation induced by ADP.

Abe H, Endo K, Shiba M, Satake M.

Transfus Apher Sci. 2019 Jun 7:102560. doi: 10.1016/j.transci.2019.06.001. [Epub ahead of print]

PMID:
31204292
2.

Effects of riboflavin and ultraviolet light treatment on platelet thrombus formation on collagen via integrin αIIbβ3 activation.

Terada C, Mori J, Okazaki H, Satake M, Tadokoro K.

Transfusion. 2014 Jul;54(7):1808-16. doi: 10.1111/trf.12566. Epub 2014 Feb 8.

PMID:
24506417
3.

Effects of riboflavin and ultraviolet light treatment on platelet thrombus formation and thrombus stability on collagen.

Terada C, Shiba M, Nagai T, Satake M.

Transfusion. 2017 Jul;57(7):1772-1780. doi: 10.1111/trf.14114. Epub 2017 Apr 17.

PMID:
28417457
4.

Platelet ADP response deteriorates in synthetic storage media.

Keuren JF, Cauwenberghs S, Heeremans J, de Kort W, Heemskerk JW, Curvers J.

Transfusion. 2006 Feb;46(2):204-12.

PMID:
16441596
5.

Plasma ectonucleotidases prevent desensitization of purinergic receptors in stored platelets: importance for platelet activity during thrombus formation.

Cauwenberghs S, Feijge MA, Hageman G, Hoylaerts M, Akkerman JW, Curvers J, Heemskerk JW.

Transfusion. 2006 Jun;46(6):1018-28.

PMID:
16734820
6.

Quantitation of coated platelet potential during collection, storage, and transfusion of apheresis platelets.

Charania R, Smith J, Vesely SK, Dale GL, Holter J.

Transfusion. 2011 Dec;51(12):2690-4. doi: 10.1111/j.1537-2995.2011.03179.x. Epub 2011 Jun 3.

PMID:
21645004
7.

Restored response to ADP downstream of purinergic P2Y12 receptor in apheresis platelets after pathogen-reducing xenon flash treatment.

Abe H, Abe T, Shiba M, Satake M.

Transfusion. 2018 May;58(5):1117-1125. doi: 10.1111/trf.14578. Epub 2018 Mar 25.

PMID:
29575062
8.

Pulsed xenon flash treatment inactivates bacteria in apheresis platelet concentrates while preserving in vitro quality and functionality.

Abe H, Shiba M, Niibe Y, Tadokoro K, Satake M.

Transfusion. 2017 Apr;57(4):989-996. doi: 10.1111/trf.13984. Epub 2017 Jan 12.

PMID:
28084008
9.
11.

Ultraviolet C light pathogen inactivation treatment of platelet concentrates preserves integrin activation but affects thrombus formation kinetics on collagen in vitro.

Van Aelst B, Devloo R, Vandekerckhove P, Compernolle V, Feys HB.

Transfusion. 2015 Oct;55(10):2404-14. doi: 10.1111/trf.13137. Epub 2015 Apr 25.

PMID:
25912149
12.

Decreased responsiveness and development of activation markers of PLTs stored in plasma.

Curvers J, van Pampus EC, Feijge MA, Rombout-Sestrienkova E, Giesen PL, Heemskerk JW.

Transfusion. 2004 Jan;44(1):49-58.

PMID:
14692967
13.

Measurement of the platelet retention rate in a column of collagen-coated beads is useful for the assessment of efficacy of antiplatelet therapy.

Mende A, Obata JE, Sano K, Hirano M, Kitta Y, Kodama Y, Nakamura T, Kawabata K, Saitoh Y, Fujioka D, Kobayashi T, Satoh K, Ozaki Y, Yano T, Kugiyama K.

Thromb Res. 2009 Apr;123(6):856-61. doi: 10.1016/j.thromres.2008.09.010. Epub 2008 Nov 12.

PMID:
19004478
14.

Mechanisms of platelet retention in the collagen-coated-bead column.

Kaneko M, Cuyun-Lira O, Takafuta T, Suzuki-Inoue K, Satoh K, Ohtsuki K, Ohnishi M, Arai M, Yatomi Y, Ozaki Y.

J Lab Clin Med. 2003 Oct;142(4):258-67.

PMID:
14625532
15.

Impact of cold storage on platelets treated with Intercept pathogen inactivation.

Six KR, Devloo R, Compernolle V, Feys HB.

Transfusion. 2019 Aug;59(8):2662-2671. doi: 10.1111/trf.15398. Epub 2019 Jun 12.

16.

Impact of high dose vitamin C on platelet function.

Mohammed BM, Sanford KW, Fisher BJ, Martin EJ, Contaifer D Jr, Warncke UO, Wijesinghe DS, Chalfant CE, Brophy DF, Fowler Iii AA, Natarajan R.

World J Crit Care Med. 2017 Feb 4;6(1):37-47. doi: 10.5492/wjccm.v6.i1.37. eCollection 2017 Feb 4.

17.

Platelet capacity of various platelet pooling systems for buffy coat-derived platelet concentrates.

Dijkstra-Tiekstra MJ, Kuipers W, Setroikromo AC, de Wildt-Eggen J.

Transfusion. 2008 Oct;48(10):2114-21. doi: 10.1111/j.1537-2995.2008.01849.x. Epub 2008 Jul 17.

PMID:
18647365
18.

Neferine exerts its antithrombotic effect by inhibiting platelet aggregation and promoting dissociation of platelet aggregates.

Zhou YJ, Xiang JZ, Yuan H, Liu H, Tang Q, Hao HZ, Yin Z, Wang J, Ming ZY.

Thromb Res. 2013 Aug;132(2):202-10. doi: 10.1016/j.thromres.2013.05.018. Epub 2013 Jun 14.

PMID:
23773522
19.

Supernates from stored red blood cells inhibit platelet aggregation.

Matheu FA, McFaul SJ.

Transfusion. 2010 Jun;50(6):1196-202. doi: 10.1111/j.1537-2995.2010.02582.x. Epub 2010 Feb 11.

PMID:
20158688
20.

Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: role of P2Y₁ and P2Y₁₂ receptors.

Aslam M, Sedding D, Koshty A, Santoso S, Schulz R, Hamm C, Gündüz D.

Thromb Res. 2013 Nov;132(5):548-57. doi: 10.1016/j.thromres.2013.08.021. Epub 2013 Sep 1.

PMID:
24071464

Supplemental Content

Support Center